| BBB | blood-brain barrier |
| NPs | nanoparticles |
| STAT | signal transducers and activator of transcription |
| DRE | DNA regulatory elements |
| Tyr | tyrosine |
| GAS | gamma-activated sites |
| ISREs | interferon-stimulated response elements |
| IFN | interferon |
| SCOS | suppressor of cytokine signaling |
| PTP | protein tyrosine phosphatase |
| PIAS | protein inhibitors of activated STATs |
| IL | interleukin |
| CRC | colorectal cancer |
| lncRNA | long non-coding RNA |
| miR | microRNA |
| Cys | cysteine |
| AHR | airway hyper responsiveness |
| RNAi | RNA interference |
| MMP | matrix metalloproteinase |
| VEGF | vascular endothelial growth factor |
| SLNs | solid lipid NPs |
| HAP | hydroxyapatite |
| TNBC | triple negative breast cancer |
| Niclo | niclosamide |
| FDA | Food and Drug Administration |
| EMT | epithelial-to-mesenchymal transition |
| MM | multiple myeloma |
| DCs | dendritic cells |
| ELTN | erlotinib |
| EGFR | epidermal growth factor receptor |
| FDTN | fedratinib |
| NSCLC | non-small cell-lung cancer |
| PEI | polyethylenimine |
| TTF1 | trimethoxyflavone |
| SS | Sorbaria sorbifolia |
| TAM | tumor-associated macrophage |
| TADCs | tumor-associated CDs |
| JAK | Janus kinase |